Articles

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

17.12.2014 BE law

Team

Related news

09.10.2017 EU law
Stibbe attends AIPPI World Congress in Sydney

Conference - The International Association for the Protection of Intellectual Property, known as AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle), is the world’s leading International Organization dedicated to the development and improvement of laws for the protection of intellectual property.

Read more

22.02.2018 BE law
27 February 2018: Ignace Vernimme speaks on IP rights within international contracts

Speaking slot - Enterprise Europe Network Vlaanderen (a professional network of regional organizations whose mission is to help innovative SMEs to conquer foreign markets) organizes a seminar in Antwerp on how to find foreign business partners and how to deal with them. Stibbe's IP partner, Ignace Vernimme, gives a presentation titled: IPRs: a key tool for innovative SMEs to conquer foreign markets.

Read more

Our website uses cookies: third party analytics cookies to best adapt our website to your needs & cookies to enable social media functionalities. For more information on the use of cookies, please check our Privacy and Cookie Policy. Please note that you can change your cookie opt-ins at any time via your browser settings.

Privacy – en cookieverklaring